RO7568282
/ Roche
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 25, 2026
TARBELA-AD: Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
(clinicaltrials.gov)
- P2 | N=450 | Not yet recruiting | Sponsor: Hoffmann-La Roche
New P2 trial • Alzheimer's Disease • CNS Disorders
August 25, 2026
TARBELA-PD: Study to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
(clinicaltrials.gov)
- P1/2 | N=474 | Not yet recruiting | Sponsor: Hoffmann-La Roche
New P1/2 trial • CNS Disorders • Movement Disorders • Parkinson's Disease
1 to 2
Of
2
Go to page
1